Vital Signsby BridgeheadAll voices

01  Voice · Sector leader · Rare diseases

Michael Sumner: no photograph is held, so the sector leader plate is shown instead.
Sector leader

Michael Sumner

Chief Medical Officer, Inovio

Press citations per month · linked articles
1
Nov 2026to date
1

press citation on 1 topic since 2 Nov 2026 · last quoted 2 Nov 2026

02  Quoted on · 1 of 29 topics

Open the topic

Michael Sumner: key facts

Kind of voice
Sector leader
Role
Chief Medical Officer, Inovio
Quoted on
Rare diseases
Tracked press citations
1
Most recently quoted
2 Nov 2026

04  The signal · where Michael Sumner sits on rare diseases

Ranked 49= of 100 voices quoted in the press on rare diseases, level with 51 others on 1 citation.

Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.

  1. 1Giles LomaxSector leaderChief Executive Officer, Spinal Muscular Atrophy UK (SMA UK)9
  2. 2Dr Harrison CarterAcademicDirector of Screening at NHS England8
  3. 3=Prof Dame Sue Hill portraitProf Dame Sue HillRegulatorChief Scientific Officer for England and Senior Responsible Officer for Genomics, NHS England7
  4. 49=Isa HouwinkClinicianM.D., Ph.D., Mayo Clinic family medicine physician and senior author of the study1
  5. 49=Jacqueline SheaAcademicPh.D., CEO of Inovio1
  6. 49=Michael SumnerSector leaderChief Medical Officer, Inovio1
  7. 49=Nathaniel MillerClinicianM.D., Mayo Clinic family medicine physician and first author of the study1
  8. 49=Frederick KaplanAcademicProfessor of molecular orthopedics, University of Pennsylvania Perelman School of Medicine1

Showing the leaders and the ranks around 49=, of 100 voices · See every voice on the topic →

05  On the record · press

What Michael Sumner has said

By outlet · linked articles
  • fiercepharma.com1

Where Michael Sumner has been quoted

  1. 01Inovio's DNA-based immunotherapy Voceryq approved by FDA for rare HPV airway diseasefiercepharma.com · 2 Nov 2026

Verbatim

“These straightforward distribution requirements should facilitate flexibility in the administration location, including the doctor's office.”
Chief Medical Officer, Inovio · Rare diseases · fiercepharma.com · 2 Nov 2026 · Read the article

Related media coverage

Recent UK press coverage of their topics, not necessarily citing them directly.

Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.